Ultragenyx Pharmaceutical Spikes 4% Following Release Of Positive Phase 2 Data
April 21, 2016 at 12:28 PM EDT
Shares of Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) gained more than 4 percent on Thursday after company reported positive interim ...
